ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure.
Hollenberg
N K
NK
Department of Radiology, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D017706:Lisinopril / Q000494:pharmacology*; D011188:Potassium / Q000097:blood; D051437:Renal Insufficiency / Q000097:blood; D012084:Renin-Angiotensin System / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology; D014633:Valine / Q000031:analogs & derivatives / Q000494:pharmacology; D000068756:Valsartan
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D013777:Tetrazoles; D000068756:Valsartan; D017706:Lisinopril; D014633:Valine; D011188:Potassium